Contineum Therapeutics Financial Ratios for Analysis 2022-2024 | CTNM

Fifteen years of historical annual and quarterly financial ratios and margins for Contineum Therapeutics (CTNM).

Annual Data

Metric Name
Current Ratio
Long-term Debt / Capital
Debt/Equity Ratio
Gross Margin
Operating Margin
EBIT Margin
EBITDA Margin
Pre-Tax Profit Margin
Net Profit Margin
Asset Turnover
Inventory Turnover Ratio
Receiveable Turnover
Days Sales In Receivables
ROE - Return On Equity
Return On Tangible Equity
ROA - Return On Assets
ROI - Return On Investment
Book Value Per Share
Operating Cash Flow Per Share
Free Cash Flow Per Share
20232022
23.296.41
--
--0.04
100.00-
32.15-
32.15-
32.15-
46.34-
6.29-
0.38-
--
--
--
-33.4426.02
-33.4426.02
17.43-47.90
-33.4426.02
-28.91-41.24
5.70-8.97
5.58-9.02

Quarterly Data

Metric Name
Current Ratio
Long-term Debt / Capital
Debt/Equity Ratio
Gross Margin
Operating Margin
EBIT Margin
EBITDA Margin
Pre-Tax Profit Margin
Net Profit Margin
Asset Turnover
Inventory Turnover Ratio
Receiveable Turnover
Days Sales In Receivables
ROE - Return On Equity
Return On Tangible Equity
ROA - Return On Assets
ROI - Return On Investment
Book Value Per Share
Operating Cash Flow Per Share
Free Cash Flow Per Share
2024-06-302024-03-312023-12-312023-06-302023-03-312022-12-31
58.9219.20----
------
------
---100.00--
---77.87--
---77.87--
------
---84.59--
---11.74--
------
------
------
------
-4.1411.13----
-4.1411.13----
-4.07-6.81----
-4.1411.13----
8.46-31.72----
-0.71-3.370.0010.09-2.300.00
-0.72-3.43-10.06-2.32-